封面
市場調查報告書
商品編碼
1741475

醫用人工材料市場按產品類型、應用、最終用戶和地區分類

Medical Engineered Materials Market, By Product Type, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 130 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025年醫用人工材料市場規模預計為315.8億美元,預計到2032年將達到756.9億美元,2025年至2032年的年複合成長率為13.3%。

報告範圍 報告詳細資訊
基準年 2024 2025年的市場規模 315.8億美元
效能數據 從2020年到2024年 預測期 2025年至2032年
預測期:2025-2032年年複合成長率: 13.30% 2032年價值預測 756.9億美元

醫學工程材料在醫療保健行業中發揮著至關重要的作用,為廣泛的應用提供創新的解決方案。這些材料經過專門設計,可滿足醫療設備、植入和設備的獨特要求。它們具有卓越的強度、耐用性和生物相容性,可確保醫療保健解決方案的安全有效。材料科學與工程的重大進步正在擴大陶瓷、金屬、聚合物和複合材料等材料在醫療保健領域的應用。正在開發的新型生物工程材料可以緊密模擬人體組織並有助於組織再生。這些進步是由改善患者預後的需求以及醫療程序和治療日益複雜所驅動的。總體而言,醫學工程材料產業在開發創新材料解決方案方面發揮關鍵作用,這些解決方案將把醫療保健提升到新的水平。

市場動態:

全球醫用人工材料市場的成長受到多種因素的推動。心血管疾病、糖尿病和癌症等慢性疾病的日益流行預計將推動對醫療設備和植入的需求。這些材料具有生物相容性、耐用性和靈活性等優異的性能,這對於開發先進的醫療設備至關重要。全球老年人口的增加促進了市場的成長。老年人口更容易患慢性疾病,需要專門治療,這就需要使用醫用人工材料。此外,材料科學的技術進步,如生物基材料和奈米技術塗層的開發,正在進一步推動市場成長。

然而,市場面臨許多挑戰。美國食品藥物管理局(FDA) 等監管機構制定的嚴格法規和品質標準,可能對市場進入者構成障礙。遵守這些法規並獲得新材料的監管核准既耗時又昂貴。此外,開發和生產醫用人工材料的高成本也可能成為市場成長的限制因素。

本研究的主要特點

  • 本研究報告對全球醫用人工材料市場進行了詳細的分析,並以2024年為基準年,給出了預測期(2025-2032)的市場規模和年複合成長率(CAGR%)。
  • 它還強調了各個領域的潛在商機,並說明了該市場的引人注目的投資提案矩陣。
  • 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的主要考察。
  • 全球醫用人工材料市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數進行的分析。
  • 本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
  • 全球醫用人工材料市場報告迎合了該行業的各個相關人員,例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
  • 可以透過用於分析全球醫用人工材料市場的各種策略矩陣來促進相關人員的決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章市場動態、法規與趨勢分析

  • 市場動態
  • 影響分析
  • 主要亮點
  • 監管情景
  • 產品發布/核准
  • PEST分析
  • 波特分析
  • 併購場景

第4章 全球醫療義肢材料市場-冠狀病毒(COVID-19)大流行的影響

  • COVID-19流行病學
  • 供需側分析
  • 經濟影響

5. 全球醫療義肢材料市場(依產品類型),2020 年至 2032 年

  • 金屬生醫材料
  • 陶瓷生醫材料
  • 聚合物生醫材料
  • 天然生醫材料
  • 複合生物材料
  • 其他

6. 全球醫療義肢材料市場(按應用分類),2020 年至 2032 年

  • 心血管系統
  • 整形外科
  • 牙科
  • 整形外科
  • 傷口癒合
  • 神經系統
  • 其他

7. 全球醫療義肢材料市場(按最終用戶分類),2020 年至 2032 年

  • 醫院
  • 診所
  • 研究機構
  • 其他

8. 2020-2032 年全球醫療義肢材料市場(按地區)

  • 北美洲
      • 美國
      • 加拿大
  • 歐洲
      • 德國
      • 英國
      • 西班牙
      • 法國
      • 義大利
      • 俄羅斯
      • 其他歐洲國家
  • 亞太地區
      • 中國
      • 印度
      • 日本
      • 澳洲
      • 韓國
      • ASEAN
      • 其他亞太地區
  • 拉丁美洲
      • 巴西
      • 阿根廷
      • 墨西哥
      • 其他拉丁美洲
  • 中東
      • 海灣合作理事會國家
      • 以色列
      • 其他中東地區
  • 非洲
      • 南非
      • 北非
      • 中部非洲

第10章 競爭格局

  • Evonik Industries AG
  • Covestro AG
  • BASF SE
  • Solvay
  • SABIC
  • Trelleborg AB
  • DSM
  • Celanese Corporation
  • DuPont de Nemours Inc.
  • Others

第 11 章 章節

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI6308

Medical Engineered Materials Market is estimated to be valued at USD 31.58 Bn in 2025 and is expected to reach USD 75.69 Bn by 2032, growing at a compound annual growth rate (CAGR) of 13.3% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 31.58 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 13.30% 2032 Value Projection: USD 75.69 Bn

Medical engineered materials play a crucial role in the healthcare industry, and provides innovative solutions for a wide range of applications. These materials are specifically designed to meet the unique requirements of medical devices, implants, and equipment. These offer exceptional strength, durability, and biocompatibility, ensuring safe and effective healthcare solutions. There has been significant advancement in materials science and engineering which has expanded the use of materials like ceramics, metals, polymers, and composites in healthcare. Newer bioengineered materials are being developed that can closely mimic human tissues and aid in tissue regeneration. The advances are driven by the need for improved patient outcomes along with increasing complexity of medical procedures and treatments. Overall, the medical engineered materials industry plays a crucial role in developing innovative materials solutions that can elevate healthcare to the next level.

Market Dynamics:

Global medical engineered materials market growth is driven by several factors. Increasing prevalence of chronic diseases such as cardiovascular disorders, diabetes, and cancer is expected to boost demand for medical devices and implants. These materials offer exceptional properties including biocompatibility, durability, and flexibility, which are crucial in the development of advanced medical devices. Rising geriatric population worldwide is contributing to the market growth. The elderly population is more susceptible to chronic diseases and requires specialized medical treatments, which necessitate the use of medical engineered materials. Moreover, technological advancements in material science, such as the development of bio-based materials and nanotechnology-based coatings, are further driving market growth.

However, the market faces few challenges. Stringent regulations and quality standards imposed by regulatory authorities, such as the U.S. Food and Drug Administration (FDA), can pose hurdles for market players. Compliance with these regulations and obtaining regulatory approvals for new materials can be time-consuming and costly. Furthermore, the high cost associated with the development and manufacturing of medical engineered materials can act as a restraint for market growth.

Key features of the study:

  • This report provides in-depth analysis of the global medical engineered materials market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global medical engineered materials market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Evonik Industries AG, Covestro AG, BASF SE, Solvay, SABIC, Trelleborg AB, DSM, Celanese Corporation, DuPont de Nemours Inc.,
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global medical engineered materials market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global medical engineered materials market

Medical Engineered Materials Market Detailed Segmentation:

  • By Product Type
    • Metallic Biomaterials
    • Ceramics Biomaterials
    • Polymeric Biomaterials
    • Natural Biomaterials
    • Composites Biomaterials
    • Others
  • By Application
    • Cardiovascular
    • Orthopedic
    • Dental
    • Plastic Surgery
    • Wound Healing
    • Neuro-logical
    • Others
  • By End User
    • Hospitals
    • Clinics
    • Research Institutions
    • Others
  • By Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles
    • Evonik Industries AG
    • Covestro AG
    • BASF SE
    • Solvay
    • SABIC
    • Trelleborg AB
    • DSM
    • Celanese Corporation
    • DuPont de Nemours Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Medical Engineered Materials Market, By Product Type
    • Medical Engineered Materials Market, By Application
    • Medical Engineered Materials Market, By End User
    • Medical Engineered Materials Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Growing prevalence of chronic diseases
    • Stringent clinical & regulatory requirements
    • Applications in personalized medicine
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Medical Engineered Materials Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Medical Engineered Materials Market, By Product Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Metallic Biomaterials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Ceramics Biomaterials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Polymeric Biomaterials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Natural Biomaterials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Composites Biomaterials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Medical Engineered Materials Market, By Application, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Cardiovascular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Orthopedic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Dental
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Plastic Surgery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Wound Healing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Neuro-logical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

7. Global Medical Engineered Materials Market , By End User, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Research Institutions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Medical Engineered Materials Market, By Region, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2021 -2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • Argentina
      • Brazil
      • Mexico
      • Rest of Latin America

9. Middle East & Africa

  • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • GCC Countries
      • Israel
      • South Africa
      • Central Africa
      • North Africa
      • Rest of Middle East

10. Competitive Landscape

  • Evonik Industries AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Covestro AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • BASF SE
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Solvay
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • SABIC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Trelleborg AB
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • DSM
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Celanese Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • DuPont de Nemours Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Others
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

11. Section

  • Research Methodology
  • About us